Title: Management of Tuberculosis Patient in Hong Kong
1Management ofTuberculosis Patientin Hong Kong
2(No Transcript)
3(No Transcript)
4Medical conditions of patients at the time
ofdeveloping TB (notified in August 1999) (Total
no. 594)
- One or more medical conditions 155 (26.09)
- Two medical conditions 16 (2.69)
- Three medical conditions 2 (0.34)
- Total number of cases analysed 594
- (Apart from this no reply received for 28 cases)
5Medical conditions of patients at the time
ofdeveloping TB (notified in August 1999) (Total
no. 594)
- Medical conditions Number
- Diabetes mellitus 72 12.12
- On steroid 8 1.35
- Chronic renal failure 18 3
- On cytotoxic drug 1 0.17
- Leukaemia/ lymphoma 4 0.67
- Malignancy 27 4.55
- Alcoholism 10 1.68
- Drug addiction 6 1.01
- Pneumoconiosis 9 1.52
- Others 20 3.37
6 7SOURCES OF CARE FOR PATIENTS WITH TUBERCULOSIS
IN HONG KONG
PATIENT WITH TUBERCULOSIS
Hospital Authority Accident and Emergency
Departments
Department of Health General out- patient clinics
Department of Health TB Chest Service 18 chest
clinics 7,000 new patients each year
PRIMARY LEVEL
Private Practitioner
Hospital Authority Chest Hospitals 5
hospitals 800 beds 7,000 in-patient episodes
Hospital Authority Specialist Out-patient Clinics
Private Hospitals
Hospital Authority General Hospital
SECONDARY LEVEL
8Classical symptoms suspicious of TB
- persistent cough for over 3 to 4 weeks
- blood in sputum
- weight loss
- persistent fever
- night sweating
9Particular points to note in the history
- previous history of TB - previous ST pattern
- coexisting medical illnesses
- occupational history - e.g., health care worker,
silicosis - contact history - e.g., ST of source case
- smoking status
- previous BCG (especially for child)
10Physical examination
- often yields negative findings
- general condition
- cervical LN
- pleural effusion
- unilateral wheeze (endobronchial involvement)
- help in differential diagnosis e.g., finger
clubbing favour CA lung
11Diagnosis
- Chest X-ray relatively simple, sensitive, but
less specific - apical lesion high positive predictive value
- If sputum smear negative, usually needs serial
film to assess activity of pneumonic shadow ?
trial of antibiotics (ddx from other community
acquired pneumonia) - Sputum examination for AFB (smear and culture)
- on 2 to 3 consecutive mornings
- identification and sensitivity tests should be
done for positive culture isolates - Further tests may be required for difficult
cases - CT scan, bronchoscopy, needle lung biopsy
- tuberculin test (usually limited use)
12Before starting anti-TB drugs
- Note contraindication to use of anti-TB drugs
- liver disease, renal disease, visual problem,
hearing problem, drug allergy, concomitant
medication - Young females counselled on pregnancy-related
issues - interaction with oral contraceptives
- avoidance of pregnancy during anti-TB treatment
- Pretreatment LFT, RFT, HIV antibody (with
consent), screening test for vision
13Before starting anti-TB drugs (Contd)
- Health education nature of disease, healthy
lifestyle, drug-adherence, possible side effects
of drugs (discoloration of body fluid) - supplemented with educational materials
- self-reporting of side effects
- Good rapport with patient
14Public Health Functions
- Notification of TB
- Contacts
- examination of close contacts
- stone-in-the-pond principle
- health education maintenance of good bodily
health and early awareness of suspicious symptoms - Health education on patients personal hygiene
15TB Notification System in Hong Kong
- (1) Prevention of the Spread of Infectious
- Diseases Regulations (under Quarantine and
- Prevention of Disease Ordinance)(Cap.141)
- (TB is a statutory notifiable disease
since 1939) - (Report to Department of Health)
- (2) Occupational Safety and Health Ordinance
- (E.g., health-care workers)
- (Prescribed period 6 months)
- (Report to Labour Department)
16- Notification form
- available from
- - any chest clinics
- DH homepage
- Completed form sent back to
- Wanchai Chest Clinic
- Fax 28346627
- Tel 25726024
17TB Notification
- Aims
- Surveillance
- Contact tracing and examination
- Identification of clusters
18- Under-notification
- A common problem
- The importance of the need to notify TB cases
should be recognised. - Guidance Notes for notification of TB
- Leung CC, Tam CM. Guidance notes for notification
of tuberculosis. Public Health Epidemiology
Bulletin 19998(4)36-9.
19Source of TB Notification
20Infectiousness of the TB patient
- Sputum smear a general guide to the
infectiouness - also severe cough, cavitatory disease
- To reduce risk of infection to others
- prompt initiation of treatment (infectivity
reduced significantly after 2 weeks of treatment
in which rifampicin is included) - health education
- personal hygiene measures
- good indoor ventilation
- screening of close contacts
- sick leave assessed on a case-to-case basis
(teachers, staff of elderly homes, etc.)
21TUBERCULOSISCHEMOTHERAPY
- DIRECTLY OBSERVED TREATMENT,
- SHORT COURSE
- to stop it at the source
22do s
TB
TB
s op
23DOT (directly observed treatment)
- Strongly recommended by WHO, crucial for
treatment success
24- Short course service programme (6 months)
- 2H3R3Z3E3 / 4H3R3
- H isoniazid R rifampicin
- Z pyrazinamide E ethambutol
- S streptomycin
- Drugs preferably taken in a single dose each
time and not in split doses - Combined drug preparations e.g., rifater,
rifinah - useful alternatives, but have to be given daily
- can avoid monotherapy
- but do not allow flexible dosage adjustment
25Treatment of tuberculosis
- The Tuberculosis Control Coordinating Committee
of the Hong Kong Department of Health and the
Tuberculosis Subcommittee of the Coordinating
Committee in Internal Medicine of the Hospital
Authority, Hong Kong. Chemotherapy of
tuberculosis in Hong Kong a consensus statement. - Hong Kong Med J 19984315-20
26During anti-TB treatment
- Initial phase follow up at least monthly (in
chest clinic, while under DOT) - to reinforce patient education
- watch out for adverse drug reactions
- routine blood tests usually not necessary unless
clinical features suspicious of hepatitis,
underlying liver disease, etc. - CXR at 2nd or 3rd month to assess progress
- Sputum
- If pretreatment sputum positive, recheck at 2nd
month to assess conversion to negativity - If still positive at 2nd month, recheck at 3rd
month
27During anti-TB treatment (Contd)
- Treatment defaulters being traced by health
nurses - Identify the underlying reasons for default, and
try to solve the problem as far as possible - Incentives/ enablers
- Tracing back of treatment defaulters IMPORTANT
for treatment success and public health control
of TB. - Defaulters are a potential persistent source of
infection in the community.
28At the end of six months treatment
- Assessment
- Repeat chest radiograph
- Sputum examination
- Health education
- Maintenance of a healthy lifestyle, awareness of
suspicious symptoms
29Complicating issues
- Examples of complicating issues
- Extensive disease
- Poor general condition
- Diagnostic dilemma
- Treatment failure due to non-adherence
- Drug resistance
- Concurrent medical diseases
- Drug reactions
- Consult when necessary, hospitalisation may be
required
30Tuberculosis- Indications for hospital admission
- 1. Complications of pulmonary tuberculosis, e.g.,
pleural effusion, pneumothorax, etc. - 2. Complications of treatment, e.g., severe
reactions like drug intolerance, hypersensitivity
reactions, hepatitis, etc. - 3. Concomitant diseases, e.g., uncontrolled DM.
- 4. Psychosocial problems, e.g., alcoholics, drug
addicts, previous defaulters. - 5. Difficulty in attending clinics for DOT, e.g.,
elderly, hemiplegic, living in remote areas, etc. - 6. Extrapulmonary TB for special investigation
31Some points for caution
- Addition phenomenon to be avoided
- Not to add a single drug to a failing regimen
- Desensitisation
- May be required for drug-induced
hypersensitivity, but be careful not to induce
drug-resistance - Ethambutol to be avoided under age 6 unless
necessary - Higher incidence of side effects of drugs in
elderly
32IMPORTANT
- Drug adherence is most important and is
vulnerable because - Long duration of treatment required
- Disappearance of symptoms before treatment
completion - Bulk of tablets mistake, GI upset and other
side effects - Stigma of TB cannot accept the fact of being
diagnosed as having TB - Health belief e.g., use of herbal or alternative
medicine - DOT is strongly recommended
- Prevent failure, relapse, drug-resistance, spread
of the disease, long-term sequelae of destroyed
lung
33TUBERCULOSIS
- Reasons for failure of chemotherapy
- Non-compliance
- Drug resistant tuberculosis
- Drug toxicity
- Failure of drug to reach site of action
- Immunosuppressed
34Conclusion
- Management of TB can be simple, but can go
wrongly easily, which can result in serious
consequences - Complicating issues may arise from time to time
- Caution required, consult when necessary
- Management
- Clinical Public Health measures Good
communication
35Components of DOTS
- 1. Government commitment to sustained TB control.
- 2. Sputum smear microscopy to detect infectious
cases. - 3. A standardized, short-course anti-TB treatment
regimen of six to eight months, with direct
observation of treatment for at least the initial
two months. - 4. A regular, uninterrupted supply of quality
anti-TB drugs. - 5. A MONITORING AND REPORTING SYSTEM to evaluate
treatment outcomes for each patient diagnosed and
the performance of the TB control programme as a
whole.
36Future activities
- Programme Forms (to be filled in for all TB
patients starting from January 2001) - Baseline characteristics of TB patient
- Clinical features and results of investigations
- Treatment outcomes at various time points up to 2
year from DOS (date of starting treatment) - The collaboration of both the PUBLIC AND PRIVATE
SECTOR in the evaluation process is very
important and very much appreciated.
37The collaboration of public and private sector in
the control of tuberculosis is very
important.THANK YOU!